Levoleucovorin and Leucovorin Agents
Customize your policy alerts
Sign up for Empire Bluecross Policy CC-0104 alerts
Get alerted when Policy CC-0104 changes without checking for updates manually.
Monitor payer policy activity
This policy governs medical-benefit coverage and clinical review, including prior authorization, for injectable levoleucovorin and leucovorin agents for methotrexate rescue or toxicity reduction, folic acid antagonist overdose, anemia, fluorouracil-based chemotherapy, and specified oncology indications.
The 2026 annual review clarified NCCN 2A indications for Khapzory/levoleucovorin, including types of B-cell lymphomas and neuroendocrine tumors.
The 2026 annual review clarified NCCN 2A indications for Vykoura/leucovorin, including types of neuroendocrine tumors.
Step therapy was updated to apply specifically to injectable agents and to include levoleucovorin agents in the criteria body.
HCPCS J3490 and C9310 were removed for Vykoura effective September 30, 2026.
HCPCS J0644 was added for Vykoura effective October 1, 2026.
ICD-10-CM codes C7B.00-C7B.09, C7B.8, E16.1, E16.3, and E16.8 were added for Vykoura, levoleucovorin, and Khapzory.
ICD-10-CM codes C82.00-C82.09 and C82.10-C82.19 were removed from levoleucovorin and Khapzory coding.
The policy updated NCCN-based recommendations for pediatric acute lymphoblastic leukemia, pediatric aggressive mature B-cell lymphomas, B-cell lymphomas, T-cell lymphomas, and Waldenström macroglobulinemia.
The policy updated the nomenclature for biliary tract cancers.
The policy revised the ICD-10-CM diagnosis code set by removing the all-diagnoses designation and adding specified oncology and related diagnosis codes and code ranges.
The policy updated the HCPCS description for J0642.
Fusilev was removed from the policy because it is a discontinued product.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.